Cover Image
市場調查報告書

胚胎著床前遺傳基因診斷市場(檢查的種類 - 染色體異常,異數性篩檢,性別選擇,單一遺傳基因疾病,組織抗原鑑定及x染色體連鎖疾病) - 全球產業分析,規模,佔有率,成長,趨勢與未來預測

Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

出版商 Transparency Market Research 商品編碼 318446
出版日期 內容資訊 英文 84 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
胚胎著床前遺傳基因診斷市場(檢查的種類 - 染色體異常,異數性篩檢,性別選擇,單一遺傳基因疾病,組織抗原鑑定及x染色體連鎖疾病) - 全球產業分析,規模,佔有率,成長,趨勢與未來預測 Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
出版日期: 2014年10月30日 內容資訊: 英文 84 Pages
簡介

在過去20年,胚胎著床前遺傳基因診斷(PGD)皆是用於檢查體外受精預後不佳的患者染色體異數性。現在由於醫學進步,而廣泛用於檢查染色體異常,異數性篩檢,性別選擇,單一遺傳基因疾病,組織抗原鑑定及x染色體連鎖疾病上。今後在體外受精患者間由於改善嬰兒出生率及降低障礙及遺傳基因異常,預測需求將逐漸擴大。

本報告提供胚胎著床前遺傳基因診斷市場現狀與未來的預測相關調查,為您彙整各市場區隔趨勢,各地區趨勢,及參與企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 全球胚胎著床前遺傳基因診斷市場概要

  • 簡介
    • 胚胎著床前遺傳基因診斷流程
    • 胚胎著床前遺傳基因診斷的應用
  • 市場趨勢
    • 促進要素
      • 妊娠的高齡化擴大了高齡產婦對PGD的需求
      • 遺傳基因疾病的發病率上升關係到胚胎著床前遺傳基因診斷的患者增加
      • 抽煙,壓力,污染等生活習慣的危險性擴大了體外受精和胚胎著床前遺傳基因診斷的需求
    • 阻礙要素
      • 體外受精相關的經濟及社會要素阻礙市場
      • 由於對體外受精和胚胎著床前遺傳基因診斷的保險給付受限,降低了患者數
    • 機會
      • 預防癌症的技術創新擴大胚胎著床前遺傳基因診斷的需求
      • 基因研究領域的進步促進市場成長
  • 法律體制
  • 波特五力分析
  • 市場魅力度分析
  • 競爭環境

第4章 全球胚胎著床前遺傳基因診斷市場:檢查類別

  • 概要
  • 比較分析
  • 染色體異常
  • 異數性篩檢
  • 性別選擇
  • 單一遺傳基因疾病
  • 組織抗原鑑定
  • x染色體連鎖疾病

第5章 全球胚胎著床前遺傳基因診斷市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 建議

第7章 企業簡介

  • Genesis Genetics
  • Genea Ltd.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics, Inc.
  • Reprogenetics LLC
  • Reproductive Genetics Institute
目錄

Title: Preimplantation Genetic Diagnosis Market (Test Type - PGD for Chromosomal Aberrations, Aneuploidy Screening, Gender Selection, Single Gene Disorders, HLA Typing and X-linked Diseases) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.

Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring.

This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market.

The market overview section explains market dynamics such as drivers, restraints and opportunities that influence the current and future status of the preimplantation genetic diagnosis market. Impact factors such as market attractiveness analysis and regulatory framework of PGD in various countries has been included in this section in order to provide a thorough analysis of the overall competitive scenario of the global preimplantation genetic diagnosis market. The report covers competitive analysis, which includes heat map analysis by key market players. Through heat map analysis, the stakeholder would be able to identify the presence of players across various segments of the market. All these factors would help market players gain a thorough understanding of the overall competitive scenario. The market players can then decide upon the business strategies and plans to be implemented in order to strengthen their position in the global market.

The global preimplantation genetic diagnosis market has been differentiated based on the types of tests and geographies. Based on the types of tests, the global preimplantation genetic diagnosis market has been segmented into six categories: PGD for chromosomal aberrations, aneuploidy screening, X-linked diseases, single gene disorder, HLA typing and gender selection. A detailed market analysis of the segments mentioned above has been provided at the global level in this study. The market analysis is based on market size and forecast in terms of USD million for the period 2013 to 2020 along with the compounded annual growth rate (CAGR %) for the period 2014 to 2020, considering 2013 as the base year.

Geographically, the global preimplantation genetic diagnosis market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section further provides market size and forecast for various types of PFD tests in each region. The market size and forecast of the regional markets is provided for the period 2012 to 2020. CAGR (%) for each region is also estimated for the period 2014 to 2020, considering 2013 as the base year. The report also includes strategic recommendations, which would help market players sustain and grow in the highly competitive market. These recommendations would also help new entrants establish a strong position in the global preimplantation genetic diagnosis market.

Company profiles section comprises key information such as company overview, financial overview, product portfolio, business strategies and recent developments about major players operating in the preimplantation genetic diagnosis market. Key players profiled in the report include Genesis Genetics, Genea Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Reprogenetics LLC and Reproductive Genetics Institute.

The global preimplantation genetic diagnosis market is segmented into the following categories:

Preimplantation Genetic Diagnosis Market, by Test Type

  • PGD for Chromosomal Aberrations
  • PGD for Aneuploidy Screening
  • PGD for Gender Selection
  • PGD for Single Gene Disorder
  • PDG for HLA Typing
  • PGD for X-linked Diseases

Preimplantation Genetic Diagnosis Market, by Geography

  • North America
    • PGD for Chromosomal Aberrations
    • PGD for Aneuploidy Screening
    • PGD for Gender Selection
    • PGD for Single Gene Disorder
    • PDG for HLA Typing
    • PGD for X-linked Diseases
  • Europe
    • PGD for Chromosomal Aberration
    • PGD for Aneuploidy Screening
    • PGD for Gender Selection
    • PGD for Single Gene Disorder
    • PDG for HLA Typing
    • PGD for X-linked Diseases
  • Asia Pacific
    • PGD for Chromosomal Aberrations
    • PGD for Aneuploidy Screening
    • PGD for Gender Selection
    • PGD for Single Gene Disorder
    • PDG for HLA Typing
    • PGD for X-linked Diseases
  • Rest of the World (RoW)
    • PGD for Chromosomal Aberrations
    • PGD for Aneuploidy Screenin
    • PGD for Gender Selection
    • PGD for Single Gene Disorder
    • PDG for HLA Typing
    • PGD for X-linked Diseases

Table of Contents

Chapter - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.4. Research Methodology
  • 1.5. List of Abbreviations

Chapter - Executive Summary

  • 2.1. Market Snapshot: Global Preimplantation Genetic Diagnosis Market
  • 2.2. Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography, 2013. 2020 (Value %)

Chapter - Global Preimplantation Genetic Diagnosis Market Overview

  • 3.1. Introduction
    • 3.1.1. Preimplantation Genetic Diagnosis Process
    • 3.1.2. Preimplantation Genetic Diagnosis Applications
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers
      • 3.2.1.1. Delay in conception results in increased demand of PGD among higher age women
      • 3.2.1.2. Increasing incidence rates of genetic diseases influencing patients to undergo PGD cycles for disease free offspring
      • 3.2.1.3. Lifestyle hazards such as smoking, stress and pollution are leading to decreased fertility resulting in increased demand for IVF and PGD
    • 3.2.2. Market Restraints
      • 3.2.2.1. Economic and social factors associated with IVF restrains the PGD market
      • 3.2.2.2. Limited insurance coverage for IVF and PGD results in less patient pool
    • 3.2.3. Market Opportunities
      • 3.2.3.1. Innovation in cancer prevention will increase the demand for PGD during forecast period
      • 3.2.3.2. Advancement in the field of genetics will propel the growth of PGD market
  • 3.3. Regulatory Framework: Preimplantation Genetic Diagnosis
  • 3.4. Porter's Five Forces Analysis for the Global Preimplantation Genetic Diagnosis Market
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of New Entrants
    • 3.4.4. Threat of Substitutes
    • 3.4.5. Competitive Rivalry
  • 3.5. Market Attractiveness Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography
  • 3.6. Competitive Landscape
    • 3.6.1. Heat Map Analysis for Key Market Players of Global Preimplantation Genetic Diagnosis Market

Chapter - Global Preimplantation Genetic Diagnosis Market, by Test Type

  • 4.1. Overview
    • 4.1.1. Global Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012. 2020 (USD Million)
  • 4.2. Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Test Type, 2013. 2020 (Value %)
  • 4.3. PGD for Chromosomal Aberrations
    • 4.3.1. Global PGD for Chromosomal Aberrations Market Revenue, 2012. 2020 (USD Million)
  • 4.4. PGD for Aneuploidy Screening
    • 4.4.1. Global PGD for Aneuploidy Screening Market Revenue, 2012. 2020 (USD Million)
  • 4.5. PGD for Gender Selection
    • 4.5.1. Global PGD for Gender Selection Market Revenue, 2012. 2020 (USD Million)
  • 4.6. PGD for Single Gene Disorder
    • 4.6.1. Global PGD for Single Gene Disorder Market Revenue, 2012. 2020 (USD Million)
  • 4.7. PGD for HLA Typing
    • 4.7.1. Global PGD for HLA Typing Market Revenue, 2012. 2020 (USD Million)
  • 4.8. PGD for X-linked diseases
    • 4.8.1. Global PGD for X-linked Diseases Market Revenue, 2012. 2020 (USD Million)

Chapter - Preimplantation Genetic Diagnosis Market, by Geography

  • 5.1. Overview
    • 5.1.1. Global Preimplantation Genetic Diagnosis Market Revenue, by Geography, 2012. 2020 (USD Million)
  • 5.2. North America
    • 5.2.1. North America Preimplantation Genetic Diagnosis Market Revenue, 2012. 2020 (USD Million)
    • 5.2.2. North America Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012. 2020 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Preimplantation Genetic Diagnosis Market Revenue, 2012. 2020 (USD Million)
    • 5.3.2. Europe Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012. 2020 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, 2012. 2020 (USD Million)
    • 5.4.2. Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012. 2020 (USD Million)
  • 5.5. Rest of the World (RoW)
    • 5.5.1. Rest of the World Preimplantation Genetic Diagnosis Market Revenue, 2012. 2020 (USD Million)
    • 5.5.2. Rest of the World Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012. 2020 (USD Million)

Chapter - Recommendations

  • 6.1. Introduction of Innovative Technologies to Reduce the Cost of Equipment and Procedure
  • 6.2. Draw from Rapidly Growing CRAMS Market in Emerging Economies

Chapter - Company Profiles

  • 7.1. Genesis Genetics
    • 7.1.1. Company Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategies
    • 7.1.5. Recent Developments
  • 7.2. Genea Ltd.
    • 7.2.1. Company Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategies
    • 7.2.5. Recent Developments
  • 7.3. Illumina, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategies
    • 7.3.5. Recent Developments
  • 7.4. Laboratory Corporation of America Holdings (LabCorp)
    • 7.4.1. Company Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategies
    • 7.4.5. Recent Developments
  • 7.5. Natera, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Financial Overview
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategies
    • 7.5.5. Recent Developments
  • 7.6. PerkinElmer, Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Financial Overview
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategies
    • 7.6.5. Recent Developments
  • 7.7. Quest Diagnostics, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Product Portfolio
    • 7.7.3. Financial Overview
    • 7.7.4. Business Strategies
    • 7.7.5. Recent Developments
  • 7.8. Reprogenetics LLC
    • 7.8.1. Company Overview
    • 7.8.2. Financial Overview
    • 7.8.3. Product Portfolio
    • 7.8.4. Business Strategies
    • 7.8.5. Recent Developments
  • 7.9. Reproductive Genetics Institute
    • 7.9.1. Company Overview
    • 7.9.2. Financial Overview
    • 7.9.3. Product Portfolio
    • 7.9.4. Business Strategies
    • 7.9.5. Recent Developments

List of Figures

  • FIG. 1: Preimplantation Genetic Diagnosis Market Segmentation
  • FIG. 2: Global Preimplantation Genetic Diagnosis Market, by Test Type, 2013 (USD Million)
  • FIG. 3: Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography, 2013 & 2020 (Value %)
  • FIG. 4: Preimplantation Genetic Diagnosis Process
  • FIG. 5: Porter's Five Forces Analysis for the Global Preimplantation Genetic Diagnosis Market
  • FIG. 6: Market Attractiveness Analysis of the Global Preimplantation Genetic Diagnosis Market, by Geography
  • FIG. 7: Heat Map Analysis for Key Market Players of Global Preimplantation Genetic Diagnosis Market
  • FIG. 8: Comparative Analysis of the Global Preimplantation Genetic Diagnosis Market, by Test Type, 2013 & 2020 (%)
  • FIG. 9: Global PGD for Chromosomal Aberrations Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10: Global PGD for Aneuploidy Screening Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11: Global PGD for Gender Selection Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12: Global PGD for Single Gene Disorder Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13: Global PGD for HLA Typing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14: Global PGD for X-linked Diseases Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15: North America Preimplantation Genetic Diagnosis Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16: Europe Preimplantation Genetic Diagnosis Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17: Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18: Rest of the World Preimplantation Genetic Diagnosis Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19: Illumina, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 20: LabCorp: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 21: PerkinElmer Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22: Quest Diagnostics: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1: List of Abbreviations
  • TABLE 1: Market Snapshot: Global Preimplantation Genetic Diagnosis Market
  • TABLE 2: Global Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 3: Global Preimplantation Genetic Diagnosis Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • TABLE 4: North America Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 5: Europe Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 6: Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 7: Rest of the World Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 - 2020 (USD Million)
Back to Top